Recent studies have shown increased levels of neuroinflammatory proteins and neural injury markers such as glial fibrillary acidic protein (GFAP), neurofilament light chain (NFL), and Tau in patients with COVID-19 in plasma or cerebrospinal fluid (CSF) (Frithiof et al., 2021). The gene discussed is MAPT; the disease is COVID-19.